Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $333.99 | $19.27 | 1,632.99% | 6,679.80x | 100.11x | 7.40x | 8.96x | 6.45x | $529.27M | 1.44% | $4.13B | 37.48 | $34.86B | 109.62 | ||
| NVO | NOVO NORDISK A S | $59.86 | $148.91 | -59.80% | 16.65x | 2.60x | 5.47x | 10.16x | 0.17x | $9.34B | 3.51% | $26.18B | 5.89 | $276.64B | 11.15 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $370.91 | $36.78 | 908.59% | 1,196.48x | 53.30x | 15.19x | 209.51x | 3.89x | $221.36M | 0.45% | $233.89M | 1.78 | $50.73B | 333.88 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.12 | $17.35 | 137.01% | 83.92x | 23.90x | 5.14x | 5.82x | 1.04x | $101.73M | 3.31% | $535.38M | 7.17 | $2.95B | 55.09 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.38 | $16.44 | -49.01% | 17.46x | 14.74x | 5.56x | 3.54x | 0.22x | -$23.64M | -5.05% | $133.17M | 2.38 | $480.05M | 7.14 | ||
| CORT | CORCEPT THERAPEUTICS INC | $37.36 | $43.13 | -13.39% | 37.36x | 33.99x | 5.22x | 6.22x | 0.37x | $162.57M | 4.20% | $631.90M | 6.10 | $3.81B | 57.76 | ||
| VCEL | VERICEL CORP | $36.59 | $9.55 | 283.24% | 140.73x | 62.93x | 7.14x | 5.75x | 1.67x | $20.38M | 1.10% | $321.86M | 6.38 | $1.85B | 63.05 | ||
| ARGX | ARGENX SE | $796.00 | $362.35 | 119.68% | 31.81x | 26.97x | 25,677.42x | 6.77x | 1.34x | $467.72M | 0.96% | $7.17B | 117.50 | $46.18B | 56.92 | ||
| KRYS | KRYSTAL BIOTECH INC | $272.13 | $115.85 | 134.89% | 39.44x | 33.92x | 21.11x | 6.93x | 1.31x | $166.02M | 2.11% | $1.14B | 39.30 | $7.51B | 38.84 | ||
| TECH | BIO-TECHNE CORP | $66.56 | $16.30 | 308.39% | 133.12x | 32.92x | 8.50x | 5.28x | 1.82x | $224.06M | 2.16% | $1.97B | 12.65 | $10.62B | 48.08 | ||
| GMAB | GENMAB A | $33.95 | $128.15 | -73.51% | 14.49x | 1.94x | 6.12x | 3.79x | 0.11x | $1.19B | 5.48% | $5.75B | 8.96 | $20.18B | 10.09 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.10 | $19.12 | -73.33% | 3.21x | -94.62x | 728.57x | 1.61x | 0.19x | -$82.36M | -29.76% | $171.23M | 3.16 | $217.26M | 2.42 | ||
| ADMA | ADMA BIOLOGICS INC | $17.93 | $12.74 | 40.79% | 20.38x | 19.98x | 8.75x | 9.90x | 0.86x | $40.73M | 0.95% | $431.19M | 1.81 | $4.28B | 24.86 | ||
| XOMA | XOMA ROYALTY CORP | $26.79 | $15.86 | 68.97% | 33.07x | 85.21x | 6.90x | 3.77x | 0.88x | -$12.41M | -3.81% | $87.94M | 7.25 | $373.18M | 13.95 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.28 | $9.85 | 55.09% | 26.34x | 16.02x | 7.58x | 5.51x | 0.86x | $119.87M | 5.95% | $365.77M | 2.78 | $2.02B | 19.51 | ||
| VCYT | VERACYTE INC | $43.45 | $12.34 | 252.16% | 111.41x | 41.30x | 6.91x | 2.73x | 1.58x | $98.21M | 2.87% | $1.26B | 15.98 | $3.16B | 55.41 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $206.81 | $72.39 | 185.71% | 89.53x | 24.58x | 16.12x | 4.28x | 1.28x | $30.76M | 0.76% | $950.17M | 48.53 | $4.38B | 42.54 | ||
| CRMD | CORMEDIX INC | $7.15 | $17.84 | -59.92% | 3.15x | 2.84x | 2.53x | 1.51x | 0.55x | $74.42M | 13.71% | $374.13M | 4.93 | $663.77M | 5.91 | ||
| MNKD | MANNKIND CORP | $5.77 | $2.78 | 107.36% | 57.70x | 52.60x | 5.64x | -39.77x | 0.96x | $43.39M | 2.44% | -$44.55M | -0.15 | $2.00B | 27.39 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.39 | $4.33 | 47.73% | 23.67x | 21.24x | 4.09x | 7.22x | 0.85x | $21.15M | 4.15% | $70.68M | 0.89 | $448.73M | 19.77 | ||
| RPRX | ROYALTY PHARMA PLC | $40.26 | $47.26 | -14.82% | 22.88x | 7.78x | 7.40x | 2.42x | 0.40x | $2.11B | 12.14% | $9.62B | 22.28 | $31.25B | 29.92 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.27 | $61.29 | -37.56% | 11.85x | 9.06x | 2.67x | 2.64x | 0.33x | $296.89M | 13.48% | $835.12M | 14.51 | $1.73B | 6.40 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $460.59 | $190.61 | 141.64% | 32.19x | 22.52x | 10.04x | 6.75x | 1.56x | $3.34B | 2.83% | $17.32B | 67.76 | $113.76B | 24.40 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.10 | $3.58 | -41.27% | 30.00x | 11.88x | 2.69x | 3.19x | 0.24x | -$11.69M | -7.00% | $52.91M | 0.67 | $163.41M | 18.42 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.71 | $51.46 | 12.16% | 21.22x | 12.81x | 3.58x | 1.83x | 0.59x | $832.13M | 7.51% | $6.06B | 31.54 | $10.43B | 13.50 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $23.20 | $6.68 | 247.12% | 66.29x | -20.89x | 2.89x | 7.32x | 1.82x | $78.64M | 2.68% | $401.17M | 3.17 | $2.93B | 31.38 | ||
| EXEL | EXELIXIS INC | $44.06 | $36.60 | 20.37% | 17.91x | 13.94x | 5.17x | 5.47x | 0.72x | $779.77M | 6.59% | $2.16B | 8.05 | $11.61B | 12.52 | ||
| HALO | HALOZYME THERAPEUTICS INC | $72.42 | $80.86 | -10.43% | 14.81x | 8.73x | 6.83x | 16.90x | 0.50x | $602.40M | 7.10% | $503.92M | 4.30 | $9.61B | 11.36 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.22 | $22.66 | 2.46% | 12.97x | 11.91x | 4.92x | 3.10x | 0.69x | $234.54M | 8.24% | $920.25M | 7.51 | $2.17B | 6.69 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $768.00 | $413.02 | 85.95% | 17.68x | 16.67x | 5.58x | 2.61x | 1.73x | $4.22B | 5.31% | $30.96B | 298.82 | $80.92B | 14.17 | ||
| MDXG | MIMEDX GROUP INC | $6.00 | $5.06 | 18.48% | 21.43x | 24.01x | 2.26x | 3.72x | 0.64x | $66.82M | 7.52% | $238.95M | 1.61 | $764.74M | 11.05 | ||
| INVA | INNOVIVA INC | $19.44 | $19.41 | 0.16% | 10.29x | 8.90x | 3.46x | 1.44x | 0.84x | $196.54M | 14.64% | $1.01B | 14.63 | $1.23B | 5.75 | ||
| UTHR | UNITED THERAPEUTICS CORP | $482.39 | $251.65 | 91.69% | 16.94x | 16.21x | 6.75x | 3.15x | 2.01x | $1.12B | 5.31% | $6.59B | 150.46 | $19.43B | 10.96 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.59 | $12.37 | 114.96% | 16.94x | 33.02x | 4.29x | 4.90x | 2.92x | $197.81M | 4.41% | $917.27M | 5.43 | $4.27B | 14.86 | ||
| INCY | INCYTE CORP | $106.33 | $77.44 | 37.31% | 17.60x | 13.21x | 4.32x | 4.49x | 0.91x | $1.20B | 5.75% | $4.65B | 23.77 | $18.45B | 10.97 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.